Neoadjuvant Therapy Before Resection of Primary Pulmonary Lymphoepithelial Carcinoma

Clin Lung Cancer. 2024 Jan 29:S1525-7304(24)00009-3. doi: 10.1016/j.cllc.2024.01.007. Online ahead of print.

Authors

Erik Wu¹, Joseph Reznicek², Anjana V Yeldandi², Jyoti D Patel³, David D Odell⁴

Affiliations

¹ Feinberg School of Medicine, Northwestern University, Chicago, IL.
² Department of Pathology, Northwestern Medicine, Northwestern University, Chicago, IL.
³ Division of Hematology and Oncology, Department of Medicine, Northwestern Medicine, Northwestern University, Chicago, IL.
⁴ Division of Thoracic Surgery, Department of Surgery, Michigan Medicine, University of Michigan, Ann Arbor, MI. Electronic address: ddodell@med.umich.edu.

PMID: 38462414
DOI: 10.1016/j.cllc.2024.01.007

No abstract available

Keywords: Case report; LEC; Lung cancer; Nivolumab; Programmed Death-Ligand 1 (PDL1).

Publication types

Case Reports